Search Results
Results found for "GPCR Therapeutics"
Posts (728)
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
diffusion, offset kinetics, and rebinding ✅ Real-world examples of how residence time—not potency—predicts therapeutic coverage ✅ Insight into cryptic intracellular GPCR sites, including allosteric modulators only accessible Drugs Change the Game For decades, drug design has treated GPCRs as surface targets. The slow-offset compound stays on target longer, maintains therapeutic effect as concentrations drop, GPCRs now have validated intracellular  allosteric sites.
- GPCR Therapeutics Expands Scientific Advisory Board
May 2022 "Seoul, South Korea, 28 April 2022 – GPCR therapeutics, Inc., a venture-backed clinical stage company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR GPCR just had a very successful first meeting including all the Scientific Advisory Board." Read more at the source #DrGPCR #GPCR #IndustryNews
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
Dr Brennan has extensive experience across all phases of clinical development, and across multiple therapeutic #biotech #lifesciences #appointment #GPCR #Oncology" Read more at the source #DrGPCR #GPCR #IndustryNews
Other Pages (260)
- Dr. Juan José Fung | Dr. GPCR Ecosystem
Juan José Fung is a Principal Scientist at GPCR Therapeutics, Inc , a drug discovery company focused Brian Kobilka , studying the dimerization of GPCRs. Dr. Juan José Fung on the web LinkedIn GPCR Therapeutics Dr. GPCR Ecosystem Unlock the Full Dr. GPCR Learning Ecosystem ✔ Full Masterclass library ✔ Terry's Pharmacology Corner ✔ Advanced GPCR courses GPCR Podcast? Leave a Review.
- Dr. Josephine (Pina) Cardarelli | Dr. GPCR Ecosystem
Pina Cardarelli, CSO for GPCR Therapeutics Inc., based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology company in the Bay Area. The company’s mission is to discover and develop highly effective cancer therapeutics by targeting heteromers She was an integral contributor to two therapeutics that are FDA approved, Yervoy and Opdivo. patents including anti-PD-1 patents, 22 EP patents, and greater than 100 global patents centered around therapeutic
- GPCR Masterclass: Advanced Pharmacology & Drug Discovery | Dr. GPCR
Tobin How to Build Breakthrough GPCR Programs <p class="font_8">Watch Now</p> Terry Hebert GPCR Signaling ">Watch Now</p> Terry Kenakin The New Frontier of GPCR Therapeutics 1 2 3 1 ... 1 2 3 ... 3 The scientists GPCR and the offered resources in my work sphere GPCR researcher Thank you for bringing this course with GPCR researcher About the GPCR Masterclass What is a GPCR Masterclass? The GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor
Events (10)
- Development of GPCR Ligands as Therapeutic DrugsTickets: $0.00March 20, 2025Â |Â 2:00 PM
- May 9, 2024Â |Â 2:00 PM
- June 25, 2026Â |Â 3:00 PM







